Bone marrow transplantation is a costly procedure. Depending on the type of transplant the rate may vary from ₹7 lakh to ₹50 ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Agios Pharmaceuticals Inc (AGIO) reports a 51% increase in net Pyrukynd revenue and outlines promising future launches and ...

Sickle cell disease can take a toll on couples, but it's entirely possible to maintain a healthy relationship, says columnist.

USA-based Agios Pharmaceuticals has announced that the ACTIVATE-Kids Phase III study of mitapivat in children aged 1 to <18 ...

Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my ...

In honor of Black History Month, we're covering five milestones in Black health history, from the good and great to the bad and ...

A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...

AGIO reports mixed fourth-quarter 2024 results. Its sole marketed drug, Pyrukynd, drives revenues year over year.

The Sickle Cell Blood Drive with the American Red Cross runs 9 a.m. to 2 p.m. Saturday at Apostolic Church of Jesus Christ, 2420 SE Bellview Ave.

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...